A 63-year-old man is admitted with a non-ST-elevation myocardial infarction and undergoes successful PCI with placement of a drug-eluting stent in the right coronary artery. He has no major bleeding risk factors. Which antiplatelet regimen is most consistent with current Canadian recommendations for the first 12 months after this event?